首页> Journal of neuro-oncology> Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.

Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.

导出原文传递

翻译打印收藏纠错

第一作者： Johann-Martin,Hempel

第一单位： Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. johann-martin.hempel@uni-tuebingen.de.;Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. johann-martin.hempel@uni-tuebingen.de.

作者： Johann-Martin,Hempel ^[1] ; Cornelia,Brendle ^[2] ; Benjamin,Bender ^[2] ; Georg,Bier ^[2] ; Marco,Skardelly ^[3] ; Irina,Gepfner-Tuma ^[4] ; Franziska,Eckert ^[5] ; Ulrike,Ernemann ^[2] ; Jens,Schittenhelm ^[6]

作者单位： Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. johann-martin.hempel@uni-tuebingen.de.;Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. johann-martin.hempel@uni-tuebingen.de. ^[1] Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. ^[2] Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Interdisciplinary Division of Neuro-Oncology, Departments of Neurology and Neurosurgery, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University, Tübingen, Germany.;Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. ^[3] Interdisciplinary Division of Neuro-Oncology, Departments of Neurology and Neurosurgery, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University, Tübingen, Germany.;Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. ^[4] Department of Radiation Oncology, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. ^[5] Institute of Neuropathology, Department of Pathology and Neuropathology, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.;Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. ^[6]

关键词 Contrast enhancement Gadolinium enhancement Glioma Prognosis Survival